GlassScriptPhysician profile
Steven Gough
NPI 1184783078
$1,560.88
in general payments reported to CMS, 2019-2025
9 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $138 · 2021: $192 · 2022: $131 · 2023: $309 · 2024: $434 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $761 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $761.03 |
| Education | $118.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $446.11 | 2024-2025 | Daxxify |
| Allergan, INC. | $247.01 | 2019-2021 | |
| Abbvie INC. | $186.26 | 2023 | |
| Galderma Laboratories, L.P. | $131.03 | 2022 | |
| Acessa Health INC. | $126.60 | 2019 | |
| Genmab U.S., INC. | $124.21 | 2024 | Tivdak |
| Intuitive Surgical, INC. | $122.75 | 2023 | Da Vinci Surgical System |
| Sage Therapeutics, LLC | $99.97 | 2020 | |
| Becton, Dickinson and Company | $76.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Gough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.